Nutritional and metabolic status of HIV-positive patients with lipodystrophy during one year of follow-up

Clinics

Volumn 66, Issue 3, 2011, Pages 407-410

  Anjos, Eloísa Marchi Dos ^a   Pfrimer, Karina ^a   Machado, Alcyone Artioli ^a   de Carvalho Cunha, Selma Freire ^a   Salomão, Roberta Garcia ^a   Monteiro, Jacqueline Pontes ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Dyslipidemia; Fibrate; HIV Positive Patients; Lipid Metabolism; Nutritional Assessment

Indexed keywords

FIBRIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRY; ARTICLE; EATING; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV ASSOCIATED LIPODYSTROPHY; HUMAN; HYPERLIPIDEMIA; LIFESTYLE; MALE; METABOLISM; MIDDLE AGED; NONPARAMETRIC TEST; NUTRITIONAL STATUS; PROSPECTIVE STUDY; TIME;

ADULT; ANTHROPOMETRY; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHOLESTEROL, HDL; EATING; FEMALE; FIBRIC ACIDS; FOLLOW-UP STUDIES; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; HYPERLIPIDEMIAS; LIFE STYLE; MALE; MIDDLE AGED; NUTRITIONAL STATUS; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; TIME FACTORS; TRIGLYCERIDES;

EID: 79957598769     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322011000300007     Document Type: Article

References (28)

1. Carr A, Samaras K, Thorisdottir A, Kaufmann GR, Chisholm DJ, Cooper DA. Diagnosis, prediction, and natural history of HIV-1 proteaseinhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study. Lancet. 1999;353:2093-9, doi: 10.1016/S0140-6736(98)08468-2.
2. Welty FK, Nasca MM, Lew NS, Gregoire S, Ruan Y. Effect of onsite Dietitian counseling on weight loss and lipid levels in an outpatient physician office. Am J Cardiol. 2007;100:73-5, doi: 10.1016/j.amjcard. 2007.02.056.
3. Holmes AL, Sanderson B, Maisiak R, Brown A, Bittner V. Dietitian Services are Associated with improved patient outcomes and the MEDIFICTS dietary assessment questionnaire is a suitable outcome measure in cardiac rehabilitation. J Am Diet Assoc. 2005;105:1533-40, doi: 10.1016/j.jada.2005.08.001.
4. Hendricks KM, Dong KR, Tang AM, Ding B, Spiegelman D, Woods MN, et al. High-fiber diet in HIV-positive men is associated with lower risk of developing fat deposition. Am J Clin Nutr. 2003;78:790-5.
5. Roubenoff R, Schmitz H, Baioros L, Layne J, Potts E, Cloutier GJ, et al. Reduction of abdominal obesity in lipodystrophy associated with human immunodeficiency virus infection by means of diet and exercise: case report and proof of principle. Clin Infect Dis. 2002;34:390-3, doi: 10.1086/ 338402.
6. Salyer J, Lyon DE, Settle J, Elswick RK, Rackley D. Coronary heart disease risks and lifestyle behaviors in persons with HIV infection. JANAC. 2006;17:3-17, doi: 10.1016/j.jana.2006.03.001.
7. Gray DRP. Micronized fenofibrate: a new fibric acid hypolipidemic agent The Annals of Pharmacotherapy. 1999;33:1083-103.
8. Centers for Diseases Control and Prevention. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep. 1992;41(RR-17):1.
9. Ministério da Saúde. Programa Nacional de Doenças Sexualmente Transmissíveis/AIDS. Revisão da definição nacional do caso de AIDS em adultos. Brasília: Ministério da Saúde, 1992;2.
10. World Health Organization. Physical status: the use and interpretation of anthropometry. WHO. 1995; Technical Report Series 854.
11. Ulijaszek SJ, Kerr DA. Anthropometric measurement error and the assessment of nutrition status. Br J Nutr. 1999;82:165-77, doi: 10.1017/ S0007114599001348.
12. Yanovski JA, Miller KD, Kino T, Friedman TC, Chrousos GP, Tsigos C, et al. Endocrine and metabolic evaluation of human immunodeficiency virus-infected patients with evidence of protease inhibitor-associated lipodystrophy. J Clin Endocrinol Metab. 1999; 84:1925-31, doi: 10.1210/jc. 84.6.1925.
13. Fields-Gardner C, Fergusson P. Nutrition Intervention in the care of persons with human immunodeficiency virus infection: Position of the American Dietetic Association (ADA) and Dietitians of Canada. Can J Diet Pract Res. 2004;65:132-5, doi: 10.3148/65.3.2004.132.
14. Grunfeld C, Pang M, Doerrler W, Shigenaga JK, Jensen P, Feingold KR. Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. J Clin Endocrinol Metab. 1992; 74:1045-52, doi: 10.1210/jc.74. 5.1045.
15. Almeida LB, Giudici KV, Jaime PC. Consumo alimentar e dislipidemia decorrente da terapia antiretroviral combinada para infecção pelo HIV: uma revisão sistemática. Arq Bras Endocrinol Metab. 2009;53:519-27.
16. Carosi G, Quiros-Roldan E, Torti C, Antinori A, Bevilacqua M, Bonadonna RC, et al. First Italian consensus statement on diagnosis, prevention and treatment of cardiovascular complications in HIVinfected patients in the HAART. Infectio. 2006;35:134-42, doi: 10.1007/ s15010-007-6295-5.
17. Nerad J, Romeyn M, Silverman E, Allen-Reid J, Dieterich D, Merchant J, et al. General nutrition management in patients infected with human immunodeficiency virus. Clin Infec Dis. 2003;36: S52-62, doi: 10.1086/ 367559.
18. Fitch KV, Anderson EJ, Hubbard JL, Carpenter SJ, Waddell WR, Caliendo AM, et al. Effects of a lifestyle modification program in HIVinfected patients with the metabolic syndrome. AIDS. 2006;20:1843-50, doi: 10.1097/01.aids.0000244203.95758.db.
19. Tien PC, Cole SR, Williams CM, Li R, Justman JE, Cohen MH, et al. Incidence of lipoatrophy and lipohypertrophy in the women's interagency HIV study. J Acquir Immune Defic Syndr. 2003;34:461-6, doi: 10. 1097/00126334-200312150-00003.
20. Brown T, Wang Z, Chu H, Palella FJ, Kingsley L, Witt MD, et al. Longitudinal anthropometric changes in HIV-infected and HIV-uninfected men. J Acquir Immune Defic Syndr. 2006;43:356-62, doi: 10.1097/ 01.qai.0000243052.73321.8e.
21. Corcoran C, Anderson EJ, Burrows B, Stanley T, Walsh M, Poulos AM, et al. Comparison of total body potassium with other techniques for measuring lean body mass in men and women with AIDS wasting. Am J Clin Nutr. 2000;72:1053-8.
22. Schwenk A, Beisenherz A, Kremer G, Diehl V, Salzberger B, Fätkenheuer G. Bioelectrical impedance analysis in HIV-infected patients treated with triple antiretroviral treatment. Am J Clin Nutr. 1999; 70:867-73.
23. Henry K, Melroe H, Huebsch J. Atorvastatin and gemfibrozil for protease-inhibitor-related lipid abnormalities. Lancet. 1998; 352:1031-2, doi: 10.1016/S0140-6736(98)00022-1.
24. Loomba RS, Arora R. Fibrates:where are we now? Ther ADV Cardiovasc Dis. 2009;3:91, doi: 10.1177/1753944708096281.
25. Staels B, Dallongeville J, Auwerx J, Schoonjas K, Leitersdorf E, Fruchart JC. Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation. 1998;98:2088-93.
26. Keech A, Simes RJ, Barter P, Best J, Scott R, Taskinen MR, et al. Effects of long-term fenofibrate therapy on cardiovascular events. Lancet. 2005;366:1849-61, doi: 10.1016/S0140-6736(05)67667-2.
27. Samineni D, Fichtenbaum CJ. Fenofibrate in the treatment of dyslipidemia associated with HIV infection. Expert Opin Drug Metab Toxicol. 2010;6:995-1004, doi: 10.1517/17425255.2010.504715.
28. Fields-Gardner C; Campa A. Position of the American Dietetics Association: Nutrition intervention and Human Immunodeficiency Virus Infection. J Am Diet Assoc. 2010;110:1105-19, doi: 10.1016/j.jada. 2010.05.020.